Parallel Bio
PrivateLast Round
Series A
Jun 12, 2025
Total Funding Raised
$25.43M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Parallel Bio is a biotechnology company that pioneers human-first drug discovery by combining immune organoids with artificial intelligence to replicate the human immune system for testing immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Parallel Bio Comparables
Compare Parallel Bio with similar companies based on industry and business-model similarity.
Parallel Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 12, 2025 | ||||
| Seed | Dec 20, 2022 | ||||
| Seed | Sep 1, 2021 |
Parallel Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Seed |
| Atypical | Series A |
| Amplo | Series A |
| Metaplanet Holdings | Series A |
| Breakout Ventures | Seed |
| Humba Ventures | Series A |
| Y Combinator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Data supports partner's FDA filing for Phase 1 trial.
- Mar 1, 2026
Executed 10 pharma contracts with strong year-over-year revenue growth.
Parallel Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Parallel Bio's valuation, stock price, and market status.